TY - JOUR
T1 - Quality of life and caregiver burden in familial frontotemporal lobar degeneration
T2 - Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort
AU - the LEFFTDS Consortium
AU - Gentry, Melanie T.
AU - Lapid, Maria I.
AU - Syrjanen, Jeremy
AU - Calvert, Kendrick
AU - Hughes, Samantha
AU - Brushaber, Danielle
AU - Kremers, Walter
AU - Bove, Jessica
AU - Brannelly, Patrick
AU - Coppola, Giovanni
AU - Dheel, Christina
AU - Dickerson, Bradley
AU - Dickinson, Susan
AU - Faber, Kelley
AU - Fields, Julie
AU - Fong, Jamie
AU - Foroud, Tatiana
AU - Forsberg, Leah
AU - Gavrilova, Ralitza
AU - Gearhart, Deb
AU - Ghoshal, Nupur
AU - Goldman, Jill
AU - Graff-Radford, Jonathan
AU - Graff-Radford, Neill
AU - Grossman, Murray
AU - Haley, Dana
AU - Heuer, Hilary
AU - Hsiung, Ging Yuek
AU - Huey, Edward
AU - Irwin, David
AU - Jones, David
AU - Jones, Lynne
AU - Kantarci, Kejal
AU - Karydas, Anna
AU - Knopman, David
AU - Kornak, John
AU - Kramer, Joel
AU - Kukull, Walter
AU - Lucente, Diane
AU - Lungu, Codrin
AU - Mackenzie, Ian
AU - Manoochehri, Masood
AU - McGinnis, Scott
AU - Miller, Bruce
AU - Pearlman, Rodney
AU - Petrucelli, Len
AU - Potter, Madeline
AU - Rademakers, Rosa
AU - Ramos, Eliana Marisa
AU - Weintraub, Sandra
N1 - Funding Information:
This work is supported by the National Institutes of Health (grants U01 AG045390, PI: Dr. Bradley F Boeve; U54 NS092089, PI: Dr. Adam L Boxer; U24 AG021886, PI: Dr. Tatiana M Foroud; and U01 AG016976, PI: Dr. Walter Anthony Kukull).
Funding Information:
informationThis work is supported by the National Institutes of Health (grants U01 AG045390, PI:?Dr.?Bradley F Boeve; U54 NS092089, PI: Dr. Adam L Boxer; U24 AG021886, PI: Dr. Tatiana M Foroud; and U01 AG016976, PI: Dr. Walter Anthony Kukull).We extend our appreciation to Drs. John Hsiao and Dallas Anderson from the National Institute on Aging, Drs. Marg Sutherland and Codrin Lungu from the National Institute of Neurological Disorders and Stroke, the staff of all centers, and particularly to our individuals and their families for their participation in this protocol.
Publisher Copyright:
© 2020 the Alzheimer's Association
PY - 2020/8/1
Y1 - 2020/8/1
N2 - Objective: The Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects evaluates familial frontotemporal lobar degeneration (FTLD) kindreds with MAPT, GRN, or C9orf72 mutations. Objectives were to examine whether health-related quality of life (HRQoL) correlates with clinical symptoms and caregiver burden, and whether self-rated and informant-rated HRQoL would correlate with each other. Methods: Individuals were classified using the Clinical Dementia Rating (CDR®) Scale plus National Alzheimer's Coordinating Center (NACC) FTLD. HRQoL was measured with DEMQOL and DEMQOL-proxy; caregiver burden with the Zarit Burden Interview (ZBI). For analysis, Pearson correlations and weighted kappa statistics were calculated. Results: The cohort of 312 individuals included symptomatic and asymptomatic individuals. CDR® plus NACC FTLD was negatively correlated with DEMQOL (r = −0.20, P =.001), as were ZBI and DEMQOL (r = −0.22, P =.0009). There was fair agreement between subject and informant DEMQOL (κ = 0.36, P <.0001). Conclusion: Lower HRQoL was associated with higher cognitive/behavior impairment and higher caregiver burden. These findings demonstrate the negative impact of FTLD on individuals and caregivers.
AB - Objective: The Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects evaluates familial frontotemporal lobar degeneration (FTLD) kindreds with MAPT, GRN, or C9orf72 mutations. Objectives were to examine whether health-related quality of life (HRQoL) correlates with clinical symptoms and caregiver burden, and whether self-rated and informant-rated HRQoL would correlate with each other. Methods: Individuals were classified using the Clinical Dementia Rating (CDR®) Scale plus National Alzheimer's Coordinating Center (NACC) FTLD. HRQoL was measured with DEMQOL and DEMQOL-proxy; caregiver burden with the Zarit Burden Interview (ZBI). For analysis, Pearson correlations and weighted kappa statistics were calculated. Results: The cohort of 312 individuals included symptomatic and asymptomatic individuals. CDR® plus NACC FTLD was negatively correlated with DEMQOL (r = −0.20, P =.001), as were ZBI and DEMQOL (r = −0.22, P =.0009). There was fair agreement between subject and informant DEMQOL (κ = 0.36, P <.0001). Conclusion: Lower HRQoL was associated with higher cognitive/behavior impairment and higher caregiver burden. These findings demonstrate the negative impact of FTLD on individuals and caregivers.
KW - C9orf72
KW - GRN
KW - MAPT
KW - TDP-43
KW - frontotemporal dementia
KW - quality of life
KW - tau
UR - http://www.scopus.com/inward/record.url?scp=85087837259&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087837259&partnerID=8YFLogxK
U2 - 10.1002/alz.12095
DO - 10.1002/alz.12095
M3 - Article
C2 - 32656921
AN - SCOPUS:85087837259
SN - 1552-5260
VL - 16
SP - 1115
EP - 1124
JO - Alzheimer's and Dementia
JF - Alzheimer's and Dementia
IS - 8
ER -